This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): CC-8490
Description: CC-8490 is an anti-cancer compound from Celgene's proprietary class of benzopyrans. CC-8490 acts on the estrogen receptor alpha (ERa) and has been shown to inhibit the proliferation of the MCF-7 human breast carcinoma cells. CC-8490 also acts against the proliferation of glioblastoma cells, independent of estrogen receptor binding.
Pink Sheet FDA and Competitiveness Council
Additional information available to subscribers only: